Kezar Life Sciences, Inc. (KZR) Financials
Stock symbol KZR is outdated, potentially delisted? Maybe it is available on other exchange?
KZR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 68.0 million | 2.8 million |
| Dec. 31, 2025 | 76.6 million | 6.6 million |
| Sept. 30, 2025 | 97.7 million | 14.8 million |
| June 30, 2025 | 109.1 million | 17.3 million |
KZR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -7.4 million | 653000 |
| Dec. 31, 2025 | -12.0 million | 1.6 million |
| Sept. 30, 2025 | -9.8 million | 2.1 million |
| June 30, 2025 | -12.8 million | 2.4 million |
KZR Net Income
No data available :(
KZR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 66.2 million | - | - |
| Dec. 31, 2025 | 71.9 million | - | 2.3 million |
| Sept. 30, 2025 | 90.2 million | 1.4 million | 3.3 million |
| June 30, 2025 | 100.8 million | 2.6 million | 344000 |
KZR Shares Outstanding
KZR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 1.5 million | 5.2 million | - |
| Dec. 31, 2025 | - | 5.1 million | 3.2 million | - |
| Sept. 30, 2025 | - | 6.9 million | 4.8 million | - |
| June 30, 2025 | - | 9.6 million | 5.0 million | - |
KZR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 176000 |
| Sept. 30, 2025 | - | 227000 |
| June 30, 2025 | - | - |
KZR
Price: $7.29
52 week price:
Earnings Per Share: -6.17 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 409400
Market Capitalization: 53.9 million